At BSKB, we combine industry knowledge with intellectual property law expertise. That’s why all of the intellectual property law attorneys and technical advisors in our Chemical Practice Group have either undergraduate or graduate degrees in chemistry or chemical engineering. Many of us began our careers as patent examiners at the United States Patent and Trademark Office (USPTO), chemists, process engineers or professors.
Our diverse technical backgrounds and experiences help us to better understand complex chemistries and highly technical engineering issues. We prepare and prosecute hundreds of chemical patent applications in the USPTO, and various foreign countries, each year.
We represent pharmaceutical and chemical companies around the world and have prosecuted chemical patents in the areas of polymer chemistry, chemical processing and synthesis, catalysts, materials science, organic and inorganic chemistry, pharmaceutical chemistry, physical chemistry and nanotechnology.
Attorneys and Professionals
September 30, 2021
Eugene Perez weighs in on the “Restoring America Invents Act”, proposed by Senators Leahy (D-VT) and Cornyn (R-TX), in an article from IPWatchdog, Inc
September 16, 2021
MaryAnne Armstrong, PhD, offers her perspective on the "impact of the America Invents Act" during the bill's 10 year anniversary in an article from IPWatchdog, Inc.
January 1, 2022
BSKB is pleased to announce that Seth S. Kim has been promoted to Partner of the firm.
November 24, 2021
The USPTO has delayed the effective date of the surcharge fee for non-DOCX filings to January 1, 2023. The PTO Announcement and Federal Register Notice can be viewed using the USPTO link found here: https://www.uspto.gov/blog/director/entry/modernizing-patent-filing-with-docx The USPTO will continue to accept DOCX specifications for non-PCT applications first filed in the U.S., for applications filed in the U.S. under the Paris Convention and for applications filed as a by-pass continuation of a PCT application without the surcharge fee. The surcharge delay allows the USPTO time for further testing and for application filers to adjust to the DOCX format. If you have any questions, please do not hesitate to contact us.